V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280011251 | 280005889 | 1.54 | null | Palliative (P) | 2013-12-30 | 2015-01-26 | Etoposide + Ifosfamide (3 days) | N | N | 280028408 | ETOPOSIDE + IFOSFAMIDE |
| 280011252 | 280005893 | 1.84 | 70.7 | Palliative (P) | 2018-01-30 | 2018-01-31 | Cisplatin+Gemcitabine (gallbladder) | N | Y | 280028410 | CISPLATIN + GEMCITABINE |
| 280011253 | 280009090 | 1.68 | 84.9 | Palliative (P) | 2016-01-13 | 2016-02-09 | CYCLOPHOSPHAMIDE | N | N | 280028420 | CYCLOPHOSPHAMIDE |
| 280011254 | 280005897 | 1.71 | 93 | Palliative (P) | 2013-01-03 | 2013-07-15 | CISPLATIN + FLUOROURACIL | null | N | 280028423 | CISPLATIN + FLUOROURACIL |
| 280011255 | 280005902 | 1.7 | 86 | Palliative (P) | 2016-03-22 | 2016-03-31 | Doxorubicin + Olaratumab | N | N | 280028429 | DOXORUBICIN + OLARATUMAB |
| 280011256 | 280005905 | null | 50.1 | Palliative (P) | 2018-05-26 | 2018-05-29 | Etoposide + Ifosfamide (3 days) | N | N | 280028433 | ETOPOSIDE + IFOSFAMIDE |
| 280011257 | 280005912 | 1.78 | 66.2 | Palliative (P) | 2015-06-04 | 2015-06-04 | Cisplatin +Fluorouracil (3 wk) | N | N | 280028450 | CISPLATIN + FLUOROURACIL |
| 280011258 | 280005915 | 1.68 | 55 | Palliative (P) | 2018-03-11 | 2018-04-13 | DE-ESCALATE TRIAL | 02 | N | 280028455 | DE-ESCALATE TRIAL |
| 280011259 | 280005920 | 1.73 | 88 | Palliative (P) | 2016-03-26 | 2016-03-27 | Carboplatin + Etoposide iv&po | 2 | N | 280028468 | CARBOPLATIN + ETOPOSIDE |
| 280011260 | 280012020 | 1.77 | 66.5 | Palliative (P) | 2015-12-01 | 2015-12-01 | VAC | N | N | 280028473 | CAV |
| 280011261 | 280005923 | 1.81 | 78.2 | Palliative (P) | 2016-05-27 | 2016-06-02 | VAI (Ifos 3g/m2) | N | N | 280028493 | VAI |
| 280011262 | 280011373 | 1.8 | 73.7 | Neo-adjuvant (N) | null | 2015-12-02 | VAC | N | N | 280028501 | CAV |
| 280011263 | 280005925 | 1.78 | 77 | Neo-adjuvant (N) | 2018-10-09 | 2018-11-02 | Doxorubicin + Ifosfamide | 02 | N | 280028502 | DOXORUBICIN + IFOSFAMIDE |
| 280011264 | 280011374 | 0 | 105 | Curative (C) | 2015-10-05 | 2015-10-12 | DE-ESCALATE TRIAL | N | N | 280028506 | DE-ESCALATE TRIAL |
| 280011265 | 280005931 | 1.81 | 72.4 | Curative (C) | 2015-02-22 | 2015-04-10 | Oxaliplatin + Modified de Gramont | null | null | 280028519 | OXALIPLATIN + MDG |
| 280011266 | 280005934 | 1.77 | 61.1 | Disease modification (D) | 2017-10-07 | 2017-10-17 | CARBOPLATIN + PACLITAXEL | N | N | 280028533 | CARBOPLATIN + PACLITAXEL |
| 280011267 | 280005934 | 1.65 | 55.1 | Curative (C) | 2017-06-15 | 2017-08-19 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | null | 280028533 | CISPLATIN + GEMCITABINE |
| 280011268 | 280005940 | 1.97 | null | Palliative (P) | 2019-12-06 | 2019-12-26 | CARBOPLATIN + PACLITAXEL | 02 | N | 280028563 | CARBOPLATIN + PACLITAXEL |
| 280011269 | 280009112 | 1.84 | 104.7 | Neo-adjuvant (N) | 2015-07-23 | 2015-08-31 | Etoposide + Ifosfamide (3 days) | null | null | 280028575 | ETOPOSIDE + IFOSFAMIDE |
| 280011270 | 280005948 | 0 | 60.35 | Palliative (P) | null | 2017-06-22 | ETOPOSIDE + IFOSFAMIDE | N | N | 280028592 | ETOPOSIDE + IFOSFAMIDE |
| 280011271 | 280005951 | 1.62 | 56.4 | Palliative (P) | 2013-11-29 | 2014-01-19 | EW EuroEwing 2012 Arm A VIDE | N | N | 280028593 | EURO-EWING |
| 280011272 | 280005954 | null | 71.5 | Curative (C) | 2015-12-31 | 2016-05-04 | Doxorubicin + Ifosfamide | N | N | 280028597 | DOXORUBICIN + IFOSFAMIDE |
| 280011273 | 280005958 | 1.59 | 65.6 | Palliative (P) | 2018-05-01 | 2018-05-02 | Cetuximab+Cisplatin+FU (> Cycle 2) | 02 | N | 280028610 | CETUXIMAB + CISPLATIN + FU |
| 280011274 | 280011929 | 1.79 | null | Curative (C) | 2015-07-21 | 2015-08-05 | Irinotecan + Modified De Gramont | N | N | 280028643 | VAI |
| 280011275 | 280005968 | 1.59 | 72.4 | null | 2018-11-08 | 2018-11-15 | EURO-EWING | 01 | N | 280028662 | EURO-EWING |
| 280011276 | 280005973 | 1.69 | null | Adjuvant (A) | 2015-10-20 | 2015-10-22 | CYCLOPHOSPHAMIDE | null | null | 280028669 | CYCLOPHOSPHAMIDE |
| 280011277 | 280012124 | null | 68 | Palliative (P) | 2014-07-04 | 2014-07-18 | Cisplatin + Gemcitabine (D 1 & 8) | Y | N | 280028678 | CISPLATIN + GEMCITABINE |
| 280011278 | 280005975 | 1.56 | 46.8 | Neo-adjuvant (N) | 2018-02-06 | 2018-03-08 | ETOPOSIDE + IFOSFAMIDE | N | null | 280028683 | ETOPOSIDE + IFOSFAMIDE |
| 280011279 | 280005977 | 0 | 106 | Curative (C) | 2013-07-04 | 2013-07-25 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 280028689 | CISPLATIN + GEMCITABINE |
| 280011280 | 280005979 | null | 105.8 | Palliative (P) | 2018-03-10 | 2018-04-15 | EW EuroEwing 99 : VIDE | N | N | 280028693 | EURO-EWING |
| 280011281 | 280011748 | 1.84 | 153 | Adjuvant (A) | 2018-07-14 | 2018-08-26 | Cisplatin+Gemcitabine (gallbladder) | N | N | 280028697 | CISPLATIN + GEMCITABINE |
| 280011282 | 280005981 | 1.66 | 74.1 | Adjuvant (A) | 2015-04-07 | 2015-06-21 | Doxorubicin + Ifosfamide | N | null | 280028706 | DOXORUBICIN + IFOSFAMIDE |
| 280011283 | 280010648 | 1.65 | null | Palliative (P) | 2014-05-12 | 2014-05-26 | CISPLATIN + GEMCITABINE | N | N | 280028712 | CISPLATIN + GEMCITABINE |
| 280011284 | 280005985 | 1.74 | 80.9 | Curative (C) | 2017-02-13 | 2017-02-13 | Etoposide + Ifosfamide (3 days) | N | N | 280028715 | ETOPOSIDE + IFOSFAMIDE |
| 280011285 | 280005986 | 1.63 | 78.5 | Palliative (P) | 2015-01-21 | 2015-05-14 | CARBOPLATIN + PACLITAXEL | N | N | 280028735 | CARBOPLATIN + PACLITAXEL |
| 280011286 | 280005990 | 1.83 | 55.1 | Palliative (P) | 2015-12-03 | 2015-12-03 | Carboplatin + Paclitaxel (weekly) | null | null | 280028739 | CARBOPLATIN + PACLITAXEL |
| 280011287 | 280010651 | 1.83 | 61.1 | Palliative (P) | 2015-11-14 | 2015-11-17 | Cisplatin +Fluorouracil (2 wk) | 02 | null | 280028765 | CISPLATIN + FLUOROURACIL |
| 280011288 | 280006006 | null | 83.7 | Adjuvant (A) | 2016-11-20 | 2016-11-21 | CARBOPLATIN + ETOPOSIDE | 02 | N | 280028794 | CARBOPLATIN + ETOPOSIDE |
| 280011289 | 280006011 | 0 | 43 | Palliative (P) | 2014-11-02 | 2014-12-07 | EW EuroEwing 99 : VActI | null | null | 280028813 | EURO-EWING |
| 280011290 | 280006012 | 1.7 | 82.9 | Palliative (P) | 2014-03-08 | 2014-03-10 | VAC | N | N | 280028814 | CAV |
| 280011291 | 280006014 | 1.81 | null | Curative (C) | 2018-03-07 | 2018-03-21 | Irinotecan + Modified De Gramont | N | N | 280028817 | IRINOTECAN + MDG |
| 280011292 | 280006018 | 1.73 | 88.4 | Curative (C) | 2017-04-21 | 2017-06-05 | FLUOROURACIL + IRINOTECAN | N | N | 280028836 | IRINOTECAN + MDG |
| 280011293 | 280006021 | 1.77 | null | Palliative (P) | 2015-01-11 | 2015-01-13 | GEMCITABINE | 2 | N | 280028851 | GEMCITABINE |
| 280011294 | 280009151 | 1.63 | 76 | Palliative (P) | null | 2017-07-10 | Doxorubicin + Olaratumab | N | N | 280028855 | DOXORUBICIN + OLARATUMAB |
| 280011295 | 280006025 | 1.77 | 69.3 | Palliative (P) | null | 2017-05-21 | Irinotecan + Modified De Gramont | 2 | N | 280028860 | IRINOTECAN + TEMOZOLOMIDE |
| 280011296 | 280006029 | 1.76 | null | Palliative (P) | 2017-06-23 | 2017-07-14 | DE-ESCALATE TRIAL | N | N | 280028863 | DE-ESCALATE TRIAL |
| 280011297 | 280010658 | 1.78 | 64.7 | Curative (C) | 2012-12-04 | 2013-11-15 | DE-ESCALATE TRIAL | N | N | 280028864 | DE-ESCALATE TRIAL |
| 280011298 | 280006033 | 1.86 | 76 | Neo-adjuvant (N) | 2013-10-07 | 2013-10-07 | Doxorubicin + Ifosfamide | N | N | 280028865 | DOXORUBICIN + IFOSFAMIDE |
| 280011299 | 280006035 | 1.67 | null | Radical (R) | 2017-02-17 | 2017-10-08 | Doxorubicin + Olaratumab | N | N | 280028879 | DOXORUBICIN + OLARATUMAB |
| 280011300 | 280006038 | 1.64 | 90.7 | Palliative (P) | 2017-04-17 | 2017-05-10 | CAV | null | null | 280028918 | CAV |